ArticleThe Journal of clinical investigation2018

Hijacking a key chromatin modulator creates epigenetic vulnerability for MYC-driven cancer.

Zhenhua Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.